The pursuit of laboratory excellence hinges on adherence to rigorous quality management systems (QMS), making the choice between standards like ISO 15
Choosing the appropriate QMS begins with accurately identifying the laboratory's primary service and client base, as each standard specifies a unique scope of application.
ISO 17025 applies broadly to any organization performing testing, sampling, or calibration. This scope includes, but is not limited to, environmental testing, materials analysis, forensic science, product conformity assessment, and manufacturing quality control. Accreditation to ISO 17025 confirms that a laboratory operates a robust QMS. It also proves the lab is technically competent to generate valid results within its specific testing and calibration fields. The standard’s focus is on the measurement process itself and the technical output delivered to a client, such as a construction firm or a government agency.
ISO 15189, conversely, is explicitly tailored for medical laboratories. The standard covers all stages of the laboratory process, including pre-examination (patient preparation and sample collection), examination (testing), and post-examination (result reporting, interpretation, and storage). Unlike the generic testing focus of ISO 17025, ISO 15189 integrates quality management with patient care and clinical governance. Its purpose is to assure the competence of medical testing services, which directly impact diagnosis, treatment, and public health outcomes. The standard is unique in its explicit consideration of the patient journey and the clinical environment in which results are used
| Standard |
Target laboratory type |
Primary focus |
Key differentiator |
| ISO 17025 |
Testing, calibration, and sampling |
Technical competence of measurement processes |
Applies to all labs, emphasizes non-clinical testing accuracy. |
| ISO 15189 |
Medical (clinical) laboratories |
Quality, competence, and patient safety across the testing continuum |
Mandatory inclusion of pre- and post-examination processes, clinical relevance. |
The technical competence requirements cover staffing qualifications, method validation, and equipment management. These requirements show key differences that reflect the distinct user needs addressed by ISO 15189 and ISO 17025.
Laboratories seeking ISO 17025 accreditation must demonstrate competence primarily through robust method validation and verification. This involves measurement uncertainty calculation and participation in proficiency testing. The standard requires detailed documentation showing that all testing methods are scientifically sound. It also mandates that the uncertainty associated with any reported result is calculated and transparently communicated to the client. Staff competence is assured through formal education, training, and experience relevant to the specific tests performed.
For ISO 15189, competence extends beyond the analytical stage. The standard requires that laboratory management appoints staff responsible for ensuring all aspects of the QMS, and it places significant emphasis on the technical and clinical competence of the personnel who interpret results. Crucially, ISO 15189 necessitates that the laboratory establish procedures to ensure the appropriateness of samples received, address issues like insufficient sample volume, and provide advice on sample types and turnaround times that directly affect patient care. The requirement for internal and external quality control is integrated with clinical interpretation. This emphasizes that the result must be medically reliable, not just technically accurate.
The core of ISO 17025 revolves around:
- Method selection and validation
- The estimation of measurement uncertainty
- Traceability of measurement results to national or international standards
Conversely, the core of ISO 15189 encompasses:
- Patient identification and consent procedures
- Biological reference intervals and critical results reporting
- Clinical collaboration and advisory services are provided by laboratory staff
Both ISO 15189 and ISO 17025 rely on risk management, but their application targets fundamentally different types of risk: patient harm versus business or structural failure.
The 2017 revision of ISO 17025 integrated a risk-based approach aligned with the overall ISO framework. This standard requires the laboratory to identify risks and opportunities associated with its activities. These might include risks related to impartiality, confidentiality, or resource availability that could jeopardize the validity of results. A failure to comply with ISO 17025 often carries financial or legal repercussions for clients, such as product recall, structural collapse, or contractual disputes. Risk mitigation efforts are focused on the control of the test environment and the prevention of technical errors that lead to invalid data.
ISO 15189 utilizes risk management specifically to ensure patient safety and well-being. The latest versions of the medical laboratory standard explicitly focus on identifying and managing risks that can lead to adverse events for patients at any point in the testing cycle. This includes risks related to correct patient identification and transport conditions of biological samples. It also covers delays in critical result reporting and potential misinterpretation of data by clinicians. The standard demands that the laboratory implement specific controls to reduce the probability and impact of harm, requiring a deeper clinical and ethical consideration than the general risk principles outlined in ISO 17025.
Laboratories must analyze the consequences of failure based on their target accreditation:
- ISO 17025 risk: Risk of invalid measurement, loss of client trust, non-compliance penalties, and compromised product quality
- ISO 15189 risk: Risk of misdiagnosis, incorrect treatment, patient mortality or morbidity, and breach of clinical governance
This distinction underscores the tailored nature of ISO 15189 to healthcare; its QMS is ultimately a mechanism for preventing clinical errors and promoting public health.
Effective documentation serves as the backbone of any quality management system, but the reporting mandates under ISO 15189 and ISO 17025 differ in what they must convey to the end-user.
Under ISO 17025, test reports are primarily technical and contractually focused. The report must contain all necessary information for the client to understand and interpret the results correctly, including:
- Identification of the testing laboratory
- Clear and unambiguous identification of the test item
- Results with units of measurement
- An estimate of the measurement uncertainty, where applicable
- Identification of the testing method used
This documentation serves as a formal, verifiable record of a contractual testing service. The report is exhaustive in its technical detail to withstand legal or regulatory scrutiny.
For ISO 15189, the reporting requirements are centered on clinical utility and communication with healthcare providers. While technical accuracy is assumed, the report must be understandable, unambiguous, and clinically relevant. Key requirements specific to the medical standard include:
- Inclusion of biological reference intervals pertinent to the patient population
- A mechanism for immediate communication of critical or “panic” results
- Consideration of format and layout to facilitate easy clinical review and comparison with previous results
- The option for expert interpretation or commentary alongside numerical results to guide clinical decision-making
The documentation system for ISO 15189 must also comprehensively cover all aspects of the patient pathway. This includes consent forms, referral criteria, and sample rejection logs. This integrated approach ensures a continuous quality loop that monitors processes before, during, and after the actual laboratory examination, creating a more extensive and clinically integrated record set than that required by ISO 17025.
Successfully implementing a quality system under either ISO 15189 or ISO 17025 requires dedication, resource allocation, and a strategic approach tailored to the laboratory’s specific context.
Accreditation to ISO 17025 typically involves four main phases after initial QMS design:
- QMS documentation: Developing manuals, procedures, and forms that meet all clauses of the standard
- Implementation: Training staff, executing internal audits, and collecting data on method performance (e.g., uncertainty budgets)
- Accreditation application: Submitting documentation to a national or international accreditation body
- On-site assessment: Hosting assessors who review records, interview staff, and witness testing procedures
Laboratories pursuing ISO 15189 must follow a similar path. However, the scope of the assessment is often broader, encompassing clinical governance and the interface with clinical services. The implementation requires close collaboration with clinical staff (nurses, physicians) to ensure compliance in the pre- and post-examination phases. These phases fall outside the remit of ISO 17025. Furthermore, the medical standard often carries mandatory requirements for traceability and participation in external quality assessment (EQA) schemes specific to human health markers.
Professionals transitioning from a basic quality system to either ISO 15189 or ISO 17025 must:
- Conduct a comprehensive gap analysis against the chosen standard’s clauses
- Allocate specific resources for training in measurement uncertainty (critical for ISO 17025) or clinical risk analysis (critical for ISO 15189)
- Establish formal mechanisms for continuous quality improvement and management review
Adopting either standard signals a commitment to quality that transcends simple compliance, serving as a powerful demonstration of technical competence in the global marketplace or clinical community.
